Data / Form D filings / NephroGenex, Inc.
NephroGenex, Inc.: Form D filings
NephroGenex, Inc., a pharmaceuticals company in Raleigh, NC, filed 2 Form D notices with the SEC between 2010 and 2015. The latest, on November 13, 2015, reports $5.5 million sold of a $28.5 million offering to 14 investors.
Find out what NephroGenex, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3200 BEECHLEAF COURT, SUITE 900, Raleigh, NC, 27604
- Phone
- (609) 986-1780
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1338095
The full lists. Form D filings in North Carolina: 984 rows, $49.20, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 13, 2015 | New notice | $28,500,000 | $5,500,000 | $23,000,000 | 14 | Nov 3, 2015 | sec.gov |
| Jul 21, 2010 | New notice | $1,000,000 | $1,000,000 | $0 | 4 | Jul 9, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert Seltzer | Director | |
| Eugen Steiner | Director | |
| Jaikrishna Patel | Executive Officer | |
| Marco Taglietti | Director | |
| Pierre Legault | Executive Officer, Director | |
| James Mitchum | Director | |
| John Hamill | Executive Officer | |
| Richard Markham | Director |
Other pharmaceuticals companies in North Carolina that filed recently
- Dignify Therapeutics, LLC $800,000 · Sep 25, 2026
Every Form D from the week of Nov 9, 2015 · All recent filings in North Carolina · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what NephroGenex, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.